miR-34a and its novel target, NLRC5, are associated with HPV16 persistence

Area of Science:

• Molecular biology
• Oncology
• Virology

Background:

• Persistent human papillomavirus (HPV) infection, especially HPV type 16, is a key cause of cervical cancer.
• The specific role of microRNAs (miRNAs) in HPV16 persistence is not well understood.
• Preliminary findings indicated a significant decrease in miR-34a levels during HPV16 infection.

Purpose of the Study:

• To investigate the role of miRNAs in HPV16 persistence.
• To identify novel interactions between miRNAs and cellular pathways involved in HPV16 infection.
• To elucidate the molecular mechanisms linking HPV16 persistence, miR-34a, and cervical cancer.

Main Methods:

• Bioinformatics analysis to predict miRNA targets.
• Dual-luciferase reporter assays with site-directed mutagenesis to validate miRNA-target interactions.
• Transfection experiments using miR-34a mimics and inhibitors in HPV16-positive cervical cells.
• Analysis of gene expression in HPV16-infected keratinocytes and human cervical samples.

Main Results:

• HPV16 infection led to a significant downregulation of miR-34a.
• NLRC5 was identified as a direct target of miR-34a.
• miR-34a mimic transfection reduced NLRC5 levels and promoted NF-κB p65 nuclear accumulation in HPV16-positive cells.
• Antagonistic expression patterns of miR-34a and NLRC5 were observed in HPV16-infected cells and patient samples.

Conclusions:

• This study uncovers a novel interaction between miR-34a and NLRC5.
• The findings suggest a new molecular pathway involving miR-34a and NLRC5 in HPV16 persistence.
• This provides a potential new target for understanding and potentially treating HPV16-associated cervical cancers.